Severe lung infections may boost lung cancer risk
Image representing Covid lung infection generated by Wix AI CANCER DIGEST – March 16, 2026 – Scientists have discovered that serious viral lung infections that require hospitalization can alter immune cells in the lungs, leaving behind chronic inflammation that may help tumors develop months or years later, but that vaccination heads off those harmful effects. The study led by Jie Sun, PhD at the University of Virginia Health looked at the harmful effects of severe Covid-19 a
Cancer treatments failing to consider older patients' preferences
A new large-scale analysis of older adults with advanced cancer reveals a stark "preference gap" in modern oncology, showing that clinical treatments rarely align with what patients actually value most.
Durvalumab boosts survival for small-cell lung cancer but at a high cost
A new cost/benefit analysis of an immunotherapy drug that showed significantly longer survival for people with an aggressive form of lung cancer, called small-cell lung cancer, concludes that the treatment might be too expensive to be worth it.
COVID-19 vaccine may have boosted survival in advanced lung cancer patients
Lung cancer patients who received COVID-19 vaccination survived nearly twice as long as similar patients who did not get the vaccine, a new observational study shows.
A new injectable cancer drug may offer hope to people with recurrent head and neck cancer
A simple injection of a new type of drug may offer new hope for patients whose head an neck cancers returns after chemotherapy and immunotherapy, results of an ongoing early phase clinical trial show.
Radiation may boost response in some immunotherapy resistant lung cancers
Clinical results suggest that radiation therapy might help overcome immunotherapy resistance in certain lung cancer patients
